| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | RETIRED EVP | Common shares without par value | 74.4K | $10.3M | $138.17 | Mar 3, 2025 | Direct |
| ABBOTT LABORATORIES | RETIRED EVP | Common shares without par value | 70.4K | $8.45M | $120.05 | Feb 29, 2024 | Direct |
| ANALOG DEVICES INC | Director | Comm Stock - $.16-2/3 value | 1.6K | $330K | $206.62 | Mar 12, 2025 | Direct |
| NEOGEN CORP | Director | Common Stock | 19.8K | $120K | $6.07 | Oct 23, 2025 | Direct |
| ANALOG DEVICES INC | Director | Restricted Stock Unit | 185 | $40.7K | $220.22 | Feb 18, 2025 | Direct |
| ANALOG DEVICES INC | Director | Comm Stock - $.16-2/3 value | 50 | $10.3K | $206.62 | Mar 12, 2025 | By Spouse |
| NEOGEN CORP | Director | Common Stock (Right to Buy) | 50.8K | Oct 23, 2025 | Direct | ||
| ABBOTT LABORATORIES | RETIRED EVP | Option (right to buy) | 45.7K | Feb 25, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NEOG | NEOGEN CORP | Oct 23, 2025 | 2 | $120K | 4 | Oct 27, 2025 | Director |
| NEOG | NEOGEN CORP | Jun 2, 2025 | 2 | $34.7K | 4 | Jun 4, 2025 | Director |
| NEOG | NEOGEN CORP | Jun 1, 2025 | 0 | $0 | 3 | Jun 4, 2025 | Director |
| ADI | ANALOG DEVICES INC | Mar 12, 2025 | 1 | $0 | 4 | Mar 14, 2025 | Director |
| ABT | ABBOTT LABORATORIES | Feb 28, 2025 | 2 | -$1.12M | 4 | Mar 4, 2025 | RETIRED EVP |
| ABT | ABBOTT LABORATORIES | Feb 25, 2025 | 2 | $0 | 4 | Feb 27, 2025 | EXECUTIVE VICE PRESIDENT |
| ADI | ANALOG DEVICES INC | Feb 18, 2025 | 1 | $0 | 4 | Feb 19, 2025 | Director |
| ADI | ANALOG DEVICES INC | Jan 9, 2025 | 0 | $0 | 3/A | Nov 13, 2025 | Director |
| ABT | ABBOTT LABORATORIES | Feb 29, 2024 | 1 | -$1M | 4 | Mar 4, 2024 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Feb 23, 2024 | 3 | -$751K | 4 | Feb 27, 2024 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Feb 21, 2024 | 2 | $0 | 4 | Feb 23, 2024 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Jan 29, 2024 | 6 | -$2.62M | 4 | Jan 31, 2024 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Dec 14, 2023 | 3 | -$954K | 4 | Dec 18, 2023 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Aug 8, 2023 | 8 | -$900K | 4 | Aug 10, 2023 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | May 2, 2023 | 3 | -$523K | 4 | May 3, 2023 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Feb 28, 2023 | 2 | -$820K | 4 | Mar 2, 2023 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Feb 17, 2023 | 2 | $0 | 4 | Feb 22, 2023 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Jun 3, 2022 | 1 | -$208K | 4 | Jun 7, 2022 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Feb 28, 2022 | 2 | -$804K | 4 | Mar 2, 2022 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Feb 18, 2022 | 2 | $0 | 4 | Feb 23, 2022 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Dec 23, 2021 | 8 | -$1.58M | 4 | Dec 28, 2021 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Dec 17, 2021 | 3 | -$679K | 4 | Dec 21, 2021 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Dec 13, 2021 | 5 | -$1.34M | 4 | Dec 15, 2021 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Dec 6, 2021 | 3 | -$385K | 4 | Dec 8, 2021 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Nov 15, 2021 | 5 | -$1.1M | 4 | Nov 17, 2021 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Sep 2, 2021 | 5 | -$808K | 4 | Sep 3, 2021 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Aug 17, 2021 | 5 | -$1.22M | 4 | Aug 19, 2021 | EXECUTIVE VICE PRESIDENT |
| ABT | ABBOTT LABORATORIES | Jun 3, 2021 | 1 | -$189K | 4 | Jun 7, 2021 | EXECUTIVE VICE PRESIDENT |